key: cord-0812241-sn70p3jd
authors: Tummalapalli, Sri Lekha; Warnock, Neil; Mendu, Mallika L.
title: The COVID-19 Pandemic Converges With Kidney Policy Transformation: Implications for CKD Population Health
date: 2020-11-07
journal: Am J Kidney Dis
DOI: 10.1053/j.ajkd.2020.10.004
sha: 1a1e6be451ca0e1a0c5416ce5a785744657ef81c
doc_id: 812241
cord_uid: sn70p3jd

nan

The novel Coronavirus Disease 2019 (COVID-19) pandemic has illustrated the vulnerability of patients with chronic kidney disease (CKD) to poor and inequitable clinical outcomes during healthcare crises. 1 Persons with CKD are at increased risk of hospital admissions and critical illness due to COVID-19. 2 Disadvantaged populations, including Black and Hispanic individuals and those with low socioeconomic status, are at disproportionate risk of both kidney disease 3 and acquiring COVID-19. For example, in a cohort of patients in Louisiana, Black patients were more likely to have CKD and be hospitalized and die from COVID-19. 4 These disparities stem from social determinants of health, including community context and access to a healthy lifestyle (contributing to CKD), household crowding and inability to work from home (precipitating COVID-19), and structural racism in access to economic opportunity. Furthermore, individuals hospitalized with COVID-19 experience high rates of acute kidney injury requiring dialysis, which may result in eventual residual CKD, potentially exacerbating existing disparities.

COVID-19 has necessitated dramatic care delivery and healthcare policy changes at a national and global level. Concurrently, we are witnessing the Advancing American Kidney Health (AAKH) initiative unfold, the most pivotal kidney health policy since the Medicare End-Stage Renal Disease entitlement of 1972. 5 The AAKH Executive Order, signed in July 2019, announced a sweeping array of nephrology initiatives, including new payment models, investments in technology and innovation, and a focus on delaying CKD progression and increasing the use of home dialysis to support improved quality of life. In this perspective, we outline COVID-19-related payment and regulatory changes and their implications for CKD care delivery and AAKH. We then recommend actions for health systems and national professional organizations to achieve optimal, equitable CKD population health in the context of COVID-19 and kidney policy transformation (Table 1) .

J o u r n a l P r e -p r o o f Early in the COVID-19 crisis, the Centers for Medicare & Medicaid Services (CMS) announced a broad set of flexibilities and waivers of quality reporting requirements. 6 Financial penalties were waived for physician practices not submitting Merit-based Incentive Payment System (MIPS) data and for many other CMS quality programs. This "regulatory relief" has had a positive reception given costs associated with quality reporting, 7 administrative burden, and uncertainty regarding whether some quality measures meaningfully improve care. Others have argued that given substantial quality of care gaps in CKD awareness, goal-directed medical therapy, and transition to kidney replacement therapy, well-designed quality, value, and population health programs are needed to make dramatic, necessary improvements in kidney care delivery. 8 The question remains: how should quality programs for kidney care be reimagined amidst the COVID-19 crisis?

Several guiding principles can advance quality programs in nephrology. First, implementing more CKD-specific, nephrology-oriented, and patient-centered measures can shift quality efforts away from solely dialysis-focused measures and enable quality measurement to drive improvements in kidney care. 8 The new Kidney Health Evaluation Measure is being incorporated into the Healthcare Effectiveness Data and Information Set for CKD detection in patients with diabetes. 9 Other quality measures, including a standardized mortality ratio, delayed ESKD progression, and home dialysis and transplant rates, are currently under development. 10 In light of the economic impact of COVID-19 on physician practices and hospitals reliant on fee-for-service payments, there will likely be a shift towards more value-based care in the upcoming decade, and these new CKD quality measures will be needed to monitor the effectiveness of care being delivered. Second, creating a Nephrology Merit-based Incentive Payment System (MIPS) Value Pathway, a more streamlined iteration of the MIPS program, would standardize a set of quality measures that J o u r n a l P r e -p r o o f nephrology practices report, allowing for cross-regional comparisons. Lastly, it is often challenging to evaluate the effectiveness of quality programs, as they are often implemented uniformly across the nation, while other policies are changing concurrently. Advocating for CMS to re-introduce quality programs differentially across the country, using randomization or staggered implementation, would allow researchers to better evaluate the impact of programs on the quality, utilization, and equity in care delivery and lead to evidence-based policy generation.

Prior to the pandemic, the US healthcare system lacked the infrastructure and incentives to ensure effective, coordinated, patient-centered care for CKD. Evidence-based population health tools, including CKD registries, 11 e-consultation, and panel management 12 can facilitate a proactive approach to CKD care and risk stratification, particularly in the context of COVID-19. However, population health strategies for CKD are incompletely implemented due to limited time, resources, and/or local expertise, as well as financial disincentives for CKD care compared with ESKD care. 13 Capitated payments for CKD care in the upcoming Kidney Care Choices model provide built-in reimbursement for CKD population health strategies, but these payment changes are limited to participants in the KCC model. 14 Accordingly, we call for the establishment of a national CKD Quality Collaborative to provide content and programmatic support for nephrology practices and health systems engaging in CKD quality efforts. For example, the American Heart Association's "Get with the Guidelines" program partners with hospitals to implement guidelines via consultation, webinars, and workshops, and has demonstrated substantial improvements in process measures of care, and reductions in length of stay and readmissions. 15 A national CKD Quality Collaborative would cultivate clinical champions, support improvement, and provide best practices for rapid-cycle implementation and J o u r n a l P r e -p r o o f evaluation through pragmatic trials. Funding for such a program is a key constraint and would require investments from national professional societies and/or funding agencies. Establishing a national CKD Quality Collaborative aligns with the first goal of AAKH to decrease the incidence of kidney failure.

During the COVID-19 pandemic, there has been limited national surveillance of CKD care parameters due to fragmented data sources and barriers to obtaining real-time data. Concurrently, outpatient visit volumes dramatically fell, with a nearly 40% cumulative visit deficit between March and June 2020. 16 For patients with late-stage CKD whose transplant evaluations, modality education, and access placements have been delayed due to COVID-19, there is an immediate need to identify and address gaps in care to avoid long-term consequences. It is unknown whether delays in care during this time period led to an increase in "crash-start" or unplanned dialysis initiations, which are associated with higher mortality. Furthermore, close monitoring of late-stage CKD is crucial to facilitate transitions to home dialysis, in line with AAKH goals, as evidence indicates that if hemodialysis is started initially, rates of switching to PD are exceedingly low after one month. 17 In sum, continued comprehensive late-stage CKD care during COVID-19, amidst an increased use of telehealth, is central to the second AAKH goal of increasing home dialysis initiation. 5

CKD care delivery dramatically changed during the pandemic, with more than 50% of ambulatory visits initially shifting to telehealth in many health systems and nephrology practices. 18 In March 2020, CMS expanded access to telehealth by lifting originating site restrictions, broadening eligible providers, and waiving several other requirements, 19 which has had several implications for nephrology care delivery as previously described. 20, 21 As a result, the "digital J o u r n a l P r e -p r o o f divide" of lower access to internet-based technology among rural, elderly, Black and/or Hispanic, and low socioeconomic status individuals, has been accentuated during the pandemic. 22 Older and disadvantaged populations are less likely to have computer or broadband internet access and also more likely to have CKD, creating challenges for nephrologists and health systems to deliver high quality care in the context of COVID-19. The internet has been foundational to receiving COVIDrelated information and accessing healthcare. As a result, it is necessary to consider creative solutions to ameliorate the effects of the digital divide on existing chronic disease inequities.

As a temporary solution, CMS instituted that reimbursement for telephone-only visits would have parity with video/audio visits retroactive to March 1, 2020, 23 and professional organizations are advocating for these changes to become permanent. 24 Longer-term national, regional, and state solutions are also needed to address the digital divide. On August 3, 2020, an Executive Order on Improving Rural Health and Telehealth Access was signed, which specified infrastructure and technology improvements, funding for preventative care, and increased rural access to healthcare. 25 Health systems caring for CKD populations also have a role. Smartphone technology may bridge digital gaps, as smartphone ownership is high even in individuals without computer or broadband internet access. 26 SMS text messaging may be a promising tool and needs further study in persons with CKD. 27 An ongoing randomized clinical trial of CKD patients is examining the effectiveness of telephone-based self-management, including low-literacy educational materials and telephone health coaching. 28 Particularly in the context of COVID-19, digital solutions for patient engagement are essential elements in a comprehensive CKD population health strategy.

In summary, COVID-19 has highlighted the vulnerability of CKD patients to worse, inequitable clinical outcomes, and necessitated fundamental changes to our health systems amidst a historic time in kidney health policy. The COVID-19 pandemic has shown us how rapidly health J o u r n a l P r e -p r o o f systems can mobilize towards a singular mission. The AAKH aims to achieve laudable goals of reducing the incidence of kidney failure and increasing rates of home dialysis utilization and kidney transplantation, and fundamentally transform how kidney care is delivered. The convergence of these events has profound implications for patients with kidney disease, and this is the time for bold kidney care innovation at a population-level. There is great urgency to implement and evaluate population health approaches to reconceptualize CKD care and fulfill the goals of AAKH in the COVID-19 reality. 

COVID-19 and Kidney Disease Disparities in the United States

Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study

Chronic Kidney Disease Surveillance System-United States

Hospitalization and Mortality among Black Patients and White Patients with Covid-19

Medicare and Medicaid Programs; Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency

US physician practices spend more than $15.4 billion annually to report quality measures

Measuring Quality in Kidney Care: An Evaluation of Existing Quality Metrics and Approach to Facilitating Improvements in Care Delivery

National Kidney Foundation. Evaluation of Kidney Health Clinical Quality Measure. Developed by the NKF Quality Measures Technical Expert Panel

Centers for Medicare & Medicaid Services (CMS) Center for Medicare and Medicaid Innovation (CMMI) Kidney Care Choices (KCC) Model. Request for Applications

Development of an electronic health record-based chronic kidney disease registry to promote population health management

National Kidney Foundation (NKF) Chronic Kidney Disease Change Package

Addressing Financial Disincentives to Improve CKD Care

Synthesizing lessons learned from get with the guidelines: the value of disease-based registries in improving quality and outcomes

The Impact of the COVID-19

Pandemic on Outpatient Visits: Practices Are Adapting to the New Normal (Commonwealth Fund

Early Delays in Insurance Coverage and Long-term Use of Home-based Peritoneal Dialysis

Technology, telehealth and nephrology: The time is now

Telehealth for Home Dialysis in COVID-19 and Beyond: A Perspective From the

Digital Denied: The Impact of Systemic Racial Discrimination on Home-Internet Adoption

The White House. Executive Order on Improving Rural Health and Telehealth Access

Smartphones help blacks, Hispanics bridge some-but not all-digital gaps with whites: Pew Research Center

Health information technology (IT) to improve the care of patients with chronic kidney disease (CKD)

The Kidney Awareness Registry and Education (KARE) study: protocol of a randomized controlled trial to enhance provider and patient engagement with chronic kidney disease